| Product Name | MF | CAS | Details |
|---|
| Emavusertib hydrochloride | C24H25N7O5.ClH | 2376399-42-5 | Details |
| eeAChE/eqBuChE-IN-1 | 2921654-26-2 | Details |
| GCN2 modulator-1 | C20H15ClF2N6O4S | 2803470-63-3 | Details |
| EGFR/AURKB-IN-1 | 3008543-34-5 | Details |
| FAK/aurora kinase-IN-1 | 2178117-69-4 | Details |
| DHX9-IN-5 | 2973398-17-1 | Details |
| EBOV-IN-3 | 2896193-40-9 | Details |
| EBOV-IN-8 | C19H24N2O3S2.C4H4O4 | 286854-12-4 | Details |
| HDAC1-IN-7 | C22H17N3O4S | 794552-20-8 | Details |
| ELQ-598 | C28H23ClF3NO6 | 3023709-99-8 | Details |
| GSK248233A | C25H24N8O3 | 850665-21-3 | Details |
| GNF-6 | C22H19F3N6O2 | 839708-29-1 | Details |
| HDAC-IN-72 | 763066-77-9 | Details |
| hMAO-B-IN-6 | C19H20N2O5 | 2764830-43-3 | Details |
| ELOVL6-IN-4 | C20H20F3N3O3S | 1170321-92-2 | Details |
| GW549390X | C15H12N2O | 135307-33-4 | Details |
| GW809897X | C26H24Cl2N6O3S | 579515-94-9 | Details |
| HDAC-IN-67 | C30H47N5O3 | 2821923-75-3 | Details |
| EP300/CBP-IN-1 | C30H32ClFN4O4 | 2638507-71-6 | Details |
| HDAC/NAMPT-IN-1 | C19H21N5O2 | 2898381-63-8 | Details |
| GA32 | C23H19N3O3S | 1386811-71-7 | Details |
| FABP4/5-IN-5 | 2862791-11-3 | Details |
| hAChE-IN-7 | 2978613-03-3 | Details |
| Fluvastatin sodium monohydrate | C24H25FNO4.Na.H2O | 201541-53-9 | Details |
| GLPG3312 | C23H21F2N5O3 | 2340388-72-7 | Details |
| HDAC6-IN-27 | 2758023-91-3 | Details |
| DNMT/HDAC-IN-1 | 2095619-17-1 | Details |
| DNA-PK-IN-12 | 2792146-91-7 | Details |
| hDHODH-IN-14 | 881826-17-1 | Details |
| hMAO-B-IN-7 | 2955577-14-5 | Details |
| GSTP1-1 inhibitor 1 | 3829-23-0 | Details |
| EGFR ligand-2 | C30H35N9O | 2737283-20-2 | Details |
| HDAC6-IN-34 | 1432508-73-0 | Details |
| EBOV-IN-7 | 68207-16-9 | Details |
| HPK1-IN-42 | 2848684-50-2 | Details |
| EMD 495235 | C20H22ClN3O5S | 811811-33-3 | Details |
| Frataxin-IN-1 | C20H23NO6 | 102616-64-8 | Details |
| EGFR-IN-102 | C37H37F2N7O2S | 2781912-10-3 | Details |
| EGFR mutant-IN-2 | C27H27F3N6O2S | 2770009-06-6 | Details |
| HDAC-IN-71 | C19H24N2O5 | 2995354-52-2 | Details |
| hERG-IN-2 | C26H27N9O2 | 2414055-95-9 | Details |
| FKBP51-Hsp90-IN-1 | C19H24N4O4S2 | 433313-64-5 | Details |
| GmhA-IN-1 | C6H14NO9P | 1606387-54-5 | Details |
| GSK_WRN3 | 2923009-50-9 | Details |
| hMAO-A-IN-1 | 1039315-88-2 | Details |
| HPPD-IN-3 | C18H16ClN7O2 | 3024245-46-0 | Details |
| DU-14 | C22H38N2O4S | 186303-55-9 | Details |
| FLS-359 | C27H26N6S | 2309398-79-4 | Details |
| FL77-24 | 2413582-39-3 | Details |
| hAChE/hBACE-1-IN-4 | C21H24N4O2 | 229476-71-5 | Details |
| Dopamine D4 receptor ligand 2 | C20H24ClN3O2 | 219125-63-0 | Details |
| GLI1-IN-1 | 2923907-92-8 | Details |
| EGFR-IN-97 | C37H36N8O2 | 3020681-05-1 | Details |
| Glucosylceramide synthase-IN-4 | 2776965-41-2 | Details |
| EP3 antagonist 5 | 499147-44-3 | Details |
| HMC-B17 | 2935913-83-8 | Details |
| HDAC4-IN-1 | 1418293-39-6 | Details |
| HDAC-IN-56 | 2814571-89-4 | Details |
| HDAC6-IN-33 | 2444302-23-0 | Details |
| EGFR-IN-105 | C20H30N4OS | 831244-98-5 | Details |
| GW632046X | C16H14N2O | 681002-67-5 | Details |
| GW701427A | C23H19N5O6 | 433224-56-7 | Details |
| Galectin-3-IN-4 | C24H22ClF2N5O5S | 2496515-38-7 | Details |
| EGFR-IN-101 | C35H47N9O2 | 2982583-44-6 | Details |
| EGFR/HER2-IN-10 | 2931499-82-8 | Details |
| DPP1-IN-1 hydrate | 2971064-13-6 | Details |
| DNMT-IN-3 | C37H39N7O | 1683516-27-9 | Details |
| GRK6-IN-3 | C17H20N4O2 | 499231-87-7 | Details |
| FGFR4-IN-17 | 3011805-61-8 | Details |
| ERK2/p38α MAPK-IN-1 | 1016427-72-7 | Details |
| DPP-4-IN-9 | C28H23N5O4 | 2906243-39-6 | Details |
| EGFR-IN-104 | C23H27N7OS | 2758904-45-7 | Details |
| EGFR kinase inhibitor 4 | C40H34N8O4 | 2922402-05-7 | Details |
| HDAC6-IN-38 | C21H21N3O3 | 3030872-95-5 | Details |
| Enpp-1-IN-19 | 2738583-25-8 | Details |
| FXIa-IN-14 | 2423992-72-5 | Details |
| FGFR-IN-13 | C23H21N5O3 | 2962941-25-7 | Details |
| DS43260857 | C19H16F3N3O3S | 1612158-07-2 | Details |
| GW759710A | C17H14FN5O | 944795-23-7 | Details |
| FKBP51-Hsp90-IN-2 | C25H27N3O2S | 601511-07-3 | Details |
| F44-A13 | 1338190-14-9 | Details |
| EGFR-IN-103 | C28H24Cl2FN7O2S | 2568506-66-9 | Details |
| EGFR/HER2-IN-11 | C23H21ClF3N5O2 | 1346176-20-2 | Details |
| EGFR kinase inhibitor 3 | C31H25N7O3S | 2922402-03-5 | Details |
| ETC-168 | C24H19N5O2 | 1464150-99-9 | Details |
| Fluopipamine | C22H26FN7O | 885902-66-9 | Details |
| HPK1-IN-41 | 2828455-23-6 | Details |
| Galectin-3-IN-3 | C25H22ClF2N7O4S | 2491661-50-6 | Details |
| EZH2-IN-18 | C24H20BrN3O3 | 2826234-37-9 | Details |
| EGFR-IN-109 | C12H16N4OS | 3019971-97-9 | Details |
| Fasudil mesylate | C14H17N3O2S.CH4O3S | 1001206-62-7 | Details |
| HDL-16 | 2373280-36-3 | Details |
| ERK2 allosteric-IN-1 | C22 H20 N6 O4 | 872591-16-7 | Details |
| FABP4/5-IN-4 | 2862795-48-8 | Details |
| FAAH-IN-8 | 2867633-84-7 | Details |
| FAK-IN-20 | 3004967-41-0 | Details |
| EZH2-IN-17 | 2489672-09-3 | Details |
| Divarasib adipate | 2762240-36-6 | Details |
| HDAC6-IN-35 | C22H25ClN2O2 | 1394615-06-5 | Details |
| EGFR/microtubule-IN-1 | 1970269-96-5 | Details |
| Product Total： Product Page： | ||||
| 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||